Summit Securities Group’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Summit Securities Group's ASTH Position: Q2 2026 in Review
Summit Securities Group sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 406 shares — an estimated $9.96K sold.
Summit Securities Group first reported a position in ASTH in Q1 2026 and held it in 1 quarter. The position peaked at $9.96K in Q1 2026. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Summit Securities Group reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
- Summit Securities Group sold 406 Astrana Health shares in Q2 2026, an estimated $9.96K.
- Summit Securities Group first reported a position in Astrana Health in Q1 2026 and held it in 1 quarter.
- Summit Securities Group's Astrana Health position peaked at $9.96K in Q1 2026.
- 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.